This Funding Opportunity Announcement invites applications from investigators seeking to conduct exploratory clinical trials designed to test new treatments for patients with Lewy Body Dementia (LBD) or Frontotemporal Dementia (FTD). Applicants may propose to conduct either Phase I or Phase II clinical trials depending on the developmental stage of the potential therapeutic, but all trials must include patients with either LBD or FTD. Proposed therapies may include novel or existing treatments that are potentially beneficial but not currently approved for use in patients with LBD or FTD. Interventions intended to prevent or delay disease progression, as well as therapies to alleviate existing clinical symptoms, are both of interest.
RFA-NS-22-056 Expiration Date November 22, 2022
